Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Pfizer Global Research and Development, New Leads Biology: Exploratory Medicinal Sciences, Groton Laboratories, MS-8118W-110, Eastern Point Road, Groton,CT 06340, USA. bruce.a.posner@pfizer.com
The pharmaceutical industry faces a number of challenges that have cumulatively led to a decline in productivity, despite increasing levels of investment in research and development. It is in this context that some researchers and business analysts are questioning the value of the high-throughput screening (HTS) paradigm for the discovery of new therapeutics. While this criticism may be premature, significant changes are occurring in HTS-driven lead discovery to address the failure of drug candidates in the clinic. This article highlights some of these changes and their potential impact.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on